Parmar, A., Timilshina, N., Emmenegger, U., Smoragiewicz, M., Sander, B., Alibhai, S. ., & Chan, K. K. (2021). A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer. Canadian Urological Association Journal, 16(3), E126–31. https://doi.org/10.5489/cuaj.7495